We have collected the most relevant information on Claudio Lorck. Open the URLs, which are collected below, and you will find all the info you are interested in.


Claudio Lorck Inventions, Patents and Patent Applications ...

    https://patents.justia.com/inventor/claudio-lorck
    Claudio Lorck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Dr. Lorck, Claudio A. – Associate Director Regulatory ...

    https://de.linkedin.com/in/dr-lorck-claudio-a-81967719
    Dr. Lorck, Claudio A. Associate Director Regulatory Policy & Intelligence bei AbbVie Deutschland GmbH & Co. K Frankfurt am Main und Umgebung, Deutschland379 Kontakte Zum Vernetzen anmelden AbbVie...

Claudio Alexander Lorck's research works | Mitsubishi ...

    https://www.researchgate.net/scientific-contributions/Claudio-Alexander-Lorck-2019258907
    Claudio Alexander Lorck's 3 research works with 56 citations and 108 reads, including: Experience in scaling-up the film coating process for theophylline sustained release pellets

Good Practice Guide: Booklet Labels

    https://guidance-docs.ispe.org/cdn-1508930728069/author-index@Authors=Lorck%2C%20Claudio/
    Author(s): Behrends, Brigitte; Glynn, David; Gram, Karen; Lingbeek-Brummelhuis, Kirsten; Lorck, Claudio; Lories, Pierre; Muller, Phillippe; Seesing, Marloes; Sonnenberg, Sascha This Guide was written to create methods for standardizing the format, design and content of clinical trial booklet labels. Because booklet labels contain vital information for testing sites and subjects, the …

US6623759B2 - Stable drug form for oral administration ...

    https://patents.google.com/patent/US6623759B2/en
    Claudio Lorck Thomas Profitlich Gerd Weiss Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) AstraZeneca AB Original Assignee AstraZeneca AB Priority date (The priority date is an assumption and is not a legal conclusion.

Annex VI to Clinical Trial Regulation 536/2014 ... - EFPIA

    https://www.efpia.eu/media/589700/annex-vi-to-clinical-trial-regulation-536-2014.pdf
    Author: Claudio A. Lorck Date: 02/03/2021 Version: final Executive summary While the current EU Good Manufacturing Practice (GMP) Annex 13 allows for the expiry date to be omitted from immediate packaging in certain circumstances, Investigational Medicinal Products that

Now you know Claudio Lorck

Now that you know Claudio Lorck, we suggest that you familiarize yourself with information on similar questions.